Shilpa Medicare-Zydus JV gets USFDA nod for Imkeldi for certain forms of leukemia, other cancers Ruchika Sharma27 Nov 2024 5:26 PM ISTKarnataka: Shilpa Medicare's Joint Venture Oncosol (50:50 JV with Liqmeds Lifecare Limited, a Zydus group company and Koana Healthcare Limited,...
Shilpa Medicare gets CDSCO panel nod to conduct Phase III clinical trials for Recombinant Human Albumin 20% Ruchika Sharma27 Nov 2024 11:30 AM ISTNew Delhi: In relation to the successful completion of Phase I clinical trials, Shilpa Medicare Ltd has announced that the Subject Expert...
Shilpa Pharma Lifesciences gets CEP from EDQM for API, Octreotide Ruchika Sharma19 Nov 2024 11:19 AM ISTKarnataka: Shilpa Medicare has announced that the Company’' 100% subsidiary, Shilpa Pharma Lifesciences Limited has received a certificate of...
Shilpa Medicare gets four USFDA observations for Bengaluru facility Ruchika Sharma4 Nov 2024 3:58 PM ISTRaichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four observations at the...
Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin Ruchika Sharma6 Oct 2024 10:00 AM ISTKarnataka: Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP) from EDQM...
Dr Sridevi Khambhampaty appointed as CEO of Shilpa Biologicals Ruchika Sharma20 Sept 2024 11:30 AM ISTKarnataka: Shilpa Medicare has announced the appointment of Dr Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals...
Shilpa Medicare gets USFDA nod for Bortezomib Injection for multiple myeloma Ruchika Sharma28 Aug 2024 11:57 AM ISTKarnataka: Shilpa Medicare Ltd has announced the U.S. Food and Food Administration (USFDA) has approved the Company's second NDA...
Shilpa Medicare successfully completes Phase 3 studies of SMLNUD07 - NorUDCA Ruchika Sharma26 Aug 2024 11:36 AM ISTShilpa Medicare Ltd plans to submit these Phase 3 clinical trial findings at the earliest to the CDSCO, India for seeking marketing authorization in...
Shilpa Medicare successfully completes Phase 1 clinical trial for Recombinant Human Albumin 20% Ruchika Sharma8 Aug 2024 4:21 PM ISTKarnataka: Shilpa Medicare Limited has announced the successful completion of its Phase 1 clinical trial for recombinant human albumin 20%...
Shilpa Pharma Lifesciences receives certificate of suitability from EDQM for Ursodeoxycholic Acid Ruchika Sharma1 Aug 2024 2:26 PM ISTKarnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP)...
Shilpa Medicare arm gets Morocco registration nod for Adalimumab Ruchika Sharma25 July 2024 4:23 PM ISTHyderabad: Shilpa Medicare has announced that Shilpa Biologicals Pvt Ltd (SBPL), a wholly owned subsidiary of the Company has received registration...
Shilpa Pharma Lifesciences Karnataka facility clears COFEPRIS-Mexico GMP inspection Ruchika Sharma25 July 2024 12:52 PM ISTKarnataka: Shilpa Medicare has announced that the Company's 100% subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical...
